Wooree Bio Co.,Ltd (KOSDAQ:082850)
South Korea · Delayed Price · Currency is KRW 1,576.00
-9.00 (-0.57%)
At close: Jun 4, 2026
Wooree Bio Co.,Ltd Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -6,678 | -9,374 | 4,743 | 15,581 | 21,822 | 33,156 |
Depreciation & Amortization | 27,503 | 27,671 | 27,531 | 31,850 | 36,194 | 35,557 |
Loss (Gain) From Sale of Assets | 203.91 | 142.36 | -317.61 | 187.34 | -117.01 | 206.37 |
Asset Writedown & Restructuring Costs | 2,623 | 2,623 | 2,327 | - | - | - |
Loss (Gain) From Sale of Investments | 27.87 | - | - | - | - | -188.71 |
Loss (Gain) on Equity Investments | 85.67 | -50.36 | 79.77 | 190.83 | 123.76 | 184.23 |
Stock-Based Compensation | 361.43 | 274.7 | 111.89 | 364.55 | 400.24 | 577.6 |
Provision & Write-off of Bad Debts | 1,098 | 1,261 | 150.23 | -755.19 | -406.89 | 1,272 |
Other Operating Activities | -12,216 | -7,054 | 3,596 | 1,660 | 16,805 | 13,164 |
Change in Accounts Receivable | 52,246 | -124,908 | 78,181 | -48,066 | 95,739 | 46,531 |
Change in Inventory | 51,433 | 24,749 | 491.06 | 6,751 | 21,742 | -12,218 |
Change in Accounts Payable | -9,927 | 166,592 | -61,166 | 27,377 | -129,941 | -50,832 |
Change in Other Net Operating Assets | -16,513 | -47,104 | -19,488 | -8,627 | -19,008 | -17,200 |
Operating Cash Flow | 90,250 | 34,823 | 36,240 | 26,515 | 43,353 | 50,208 |
Operating Cash Flow Growth | - | -3.91% | 36.68% | -38.84% | -13.65% | -27.68% |
Capital Expenditures | -22,657 | -21,847 | -81,951 | -10,497 | -13,268 | -11,620 |
Sale of Property, Plant & Equipment | 5,304 | 5,649 | 1,090 | 106.47 | 801.23 | 1,198 |
Sale (Purchase) of Intangibles | 652.97 | -210.58 | -1,172 | -68.93 | -157.01 | -1,145 |
Investment in Securities | 7,196 | 14,704 | 28,344 | 5,121 | -29,565 | -6,216 |
Other Investing Activities | 382.95 | 486.85 | -459.46 | -148.51 | -259.59 | -173.33 |
Investing Cash Flow | -9,121 | -1,217 | -54,058 | -5,498 | -42,453 | -17,816 |
Short-Term Debt Issued | - | 84,523 | 74,516 | 85,512 | 106,100 | 104,368 |
Long-Term Debt Issued | - | 4,815 | 43,681 | - | - | 7,878 |
Total Debt Issued | 81,346 | 89,338 | 118,197 | 85,512 | 106,100 | 112,246 |
Short-Term Debt Repaid | - | -76,190 | -74,076 | -99,608 | -119,159 | -94,896 |
Long-Term Debt Repaid | - | -9,296 | -15,827 | -16,148 | -9,138 | -22,638 |
Total Debt Repaid | -83,536 | -85,486 | -89,903 | -115,755 | -128,296 | -117,534 |
Net Debt Issued (Repaid) | -2,191 | 3,852 | 28,294 | -30,243 | -22,196 | -5,288 |
Issuance of Common Stock | - | - | 18.44 | 354.26 | 904.35 | 1,766 |
Other Financing Activities | -200 | -200 | -1,603 | 539.85 | 9.74 | -49.18 |
Financing Cash Flow | -2,391 | 3,652 | 26,709 | -29,349 | -21,282 | -3,571 |
Foreign Exchange Rate Adjustments | 5,329 | 293.6 | 377.03 | 2,462 | 601.25 | 1,419 |
Miscellaneous Cash Flow Adjustments | - | - | 0 | 0 | 0 | -0 |
Net Cash Flow | 84,067 | 37,552 | 9,268 | -5,871 | -19,781 | 30,240 |
Free Cash Flow | 67,592 | 12,976 | -45,711 | 16,018 | 30,085 | 38,588 |
Free Cash Flow Growth | - | - | - | -46.76% | -22.04% | -26.03% |
Free Cash Flow Margin | 6.66% | 1.24% | -3.69% | 1.27% | 2.22% | 2.50% |
Free Cash Flow Per Share | 1432.37 | 274.88 | -963.73 | 337.94 | 647.10 | 806.13 |
Cash Interest Paid | 5,346 | 6,575 | 4,656 | 5,831 | 4,843 | 4,116 |
Cash Income Tax Paid | 16,028 | 17,327 | 13,846 | 7,031 | 3,392 | 5,270 |
Levered Free Cash Flow | 65,887 | 17,281 | -48,458 | 10,249 | 18,074 | 18,010 |
Unlevered Free Cash Flow | 69,391 | 21,111 | -45,082 | 14,031 | 21,167 | 20,783 |
Change in Working Capital | 77,240 | 19,329 | -1,982 | -22,564 | -31,468 | -33,719 |